GlucoTrack Cash Flow Statement

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	2023	2022	2021	2020	2019	2018 - 2008
Net Income	-7.1	-4.44	-4.07	-2.7	-3.52	Upgrade
Depreciation & Amortization	0.01	0.02	0.04	0.05	0.05	Upgrade
Share-Based Compensation	0.34	0.49	0.26	0.19	0.51	Upgrade
Other Operating Activities	0.19	0.2	-0.01	-1.04	-0.95	Upgrade
Operating Cash Flow	-6.56	-3.73	-3.77	-3.5	-3.9	Upgrade
Capital Expenditures	0	0	-0	-0.05	-0.02	Upgrade
Investing Cash Flow	0	0	-0	-0.05	-0.02	Upgrade
Share Issuance / Repurchase	8.73	0	0	13.01	4.2	Upgrade
Financing Cash Flow	8.73	0	0	13.01	4.2	Upgrade
Exchange Rate Effect	-0	-0.05	-0	-0.05	0.05	Upgrade
Net Cash Flow	2.17	-3.78	-3.77	9.41	0.33	Upgrade
Free Cash Flow	-6.56	-3.73	-3.77	-3.55	-3.92	Upgrade
Free Cash Flow Margin	-	-	-	-	-1885.58%	Upgrade
Free Cash Flow Per Share	-1.58	-1.21	-1.22	-1.18	-1.65	Upgrade

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).